ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF ( )-VERBENONE BY LIVER MICROSOMES
|
|
- Erick Barnett
- 5 years ago
- Views:
Transcription
1 /03/ $7.00 DRUG METABOLISM AND DISPOSITION Vol. 31, No. 8 Copyright 2003 by The American Society for Pharmacology and Experimental Therapeutics 1076/ DMD 31: , 2003 Printed in U.S.A. ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF ( )-VERBENONE BY LIVER MICROSOMES MITSUO MIYAZAWA, ATSUSHI SUGIE, AND TSUTOMU SHIMADA Department of Applied Chemistry, Faculty of Science and Engineering, Kinki University, Kowakae, Higashiosaka, Osaka, Japan (M.M., A.S.); and Osaka Prefectual Institute of Public Health, Osaka, Japan (T.S.) (Received February 4, 2003; accepted April 25, 2003) This article is available online at ABSTRACT: ( )-Verbenone, a monoterpene bicyclic ketone, is a component of the essential oil from rosemary species such as Rosmarinus officinalis L., Verbena triphylla, and Eucalyptus globulus and is used for an herb tea, a spice, and a perfume. In this study, ( )-verbenone was found to be converted to 10-hydroxyverbenone by rat and human liver microsomal cytochrome P450 (P450) enzymes. The product formation was determined by high-performance liquid chromatography with UV detection at 251 nm. There was a good correlation between activities of coumarin 7-hydroxylation and ( )-verbenone 10-hydroxylation catalyzed by liver microsomes of 16 human samples, indicating that CYP2A6 is a principal enzyme in ( )-verbenone 10-hydroxylation in humans. Human recombinant CYP2A6 and CYP2B6 catalyzed ( )- verbenone 10-hydroxylation at V max values of 15 and 21 nmol/min/ nmol P450 with apparent K m values of 16 and 91 M, respectively. In contrast, rat CYP2A1 and 2A2 did not catalyze ( )-verbenone 10- Verbenone, a monoterpene bicyclic ketone, has been shown to be a component of the essential oil from rosemary species such as Rosmarinus officinalis L., Verbena triphylla, and Eucalyptus globulus (Ravid et al., 1997; Giorgio et al., 2002). ( )-Verbenone enantiomer has a spicy odor and camphoraceous fragrance and has been used for an herb tea, a spice, and a perfume (Ravid et al., 1997; Giorgio et al., 2002). It has not previously been reported whether verbenone enantiomers or their metabolites have any biological and toxicological potencies in mammals when these chemicals are ingested into animals and humans. Our previous studies have demonstrated that several terpenes, 1,4- cineole, 1,8-cineole, and ( )- and ( )-limonenes are catalyzed by cytochrome P450 (P450 1 ) enzymes to their respective oxidation products in rat and human liver microsomes (Miyazawa et al., 2001a,b; 2002a,b). 1,4-Cineole and 1,8-cineole have been determined to be oxidized at the 2-position of the molecules both by rat and human CYP3A enzymes (Miyazawa et al., 2001a,b). Limonene enantiomers are metabolized to their respective carveols and perillyl alcohols in This work was supported in part by grants from the Ministry of Education, Science, and Culture of Japan, and the Ministry of Health and Welfare of Japan. 1 Abbreviations used are: P450, cytochrome P450; HPLC, high-performance liquid chromotography; PB, phenobarbital; thiotepa, triethylenethiophosphoramide. Address correspondence to: Dr. Mitsuo Miyazawa, Department of Applied Chemistry, Faculty of Science and Engineering, Kinki University, Kowakae, Higashiosaka, Osaka , Japan. ; miyazawa@apch.kindai.ac.jp hydroxylation at all, suggesting that there were species-related differences in the catalytic properties of human and rat CYP2A enzymes in the metabolism of ( )-verbenone. In the rat, recombinant CYP2C11, CYP2B1, and CYP3A2 catalyzed ( )-verbenone 10-hydroxylation with V max and K m ratios (ml/min/nmol P450) of 0.73, 0.20, and 0.03, respectively. Male-specific CYP2C11 was a major enzyme in ( )-verbenone 10-hydroxylation by untreated rat livers, and CYP2B1 catalyzed this reaction in liver microsomes of phenobarbital-treated rats. Rat CYP2C12, a female-specific enzyme, did not catalyze ( )- verbenone 10-hydroxylation. These results suggest that human CYP2A6 and rat CYP2C11 are the major catalysts in the metabolism of ( )-verbenone by liver microsomes and that there are speciesrelated differences in human and rat CYP2A enzymes and sex-related differences in male and female rats in the metabolism of ( )-verbenone. liver microsomes of mice, rats, guinea pigs, rabbits, dogs, monkeys, and humans (Miyazawa et al., 2002a,b). There are species-related differences in the metabolism of carveols to carvone in which dogs, rabbits, and guinea pigs catalyze this reaction, although other species of animals examined do not (Shimada et al., 2002b). It has also been reported that there are sex-related differences in the metabolism of limonene enantiomers in rats, in which male-specific CYP2C11 catalyzes limonene metabolism, although female-specific CYP2C12 does not (Miyazawa et al., 2002a). Recently we have established that human liver microsomes catalyze 10-hydroxylation of ( )-verbenone enantiomers by analysis with gas chromatography-mass spectrometry (Miyazawa et al., 2002c). Since P450 enzymes are likely to be involved in the 10-hydroxylation of ( )-verbenone, we examined which P450 species are the major enzymes in the metabolism of ( )-verbenone in liver microsomes of rats and humans. ( )-Verbenone was incubated in the presence of an NADPHgenerating system with liver microsomes of rats treated with different chemical inducers and with liver microsomes of different human liver samples. Recombinant rat and human P450 enzymes expressed in Trichoplusia ni cells were also used. The product formation was measured with HPLC using a C m analytical column. Materials and Methods Chemicals. ( )-Verbenone and its 10-hydroxylated metabolite were synthesized as described previously (Miyazawa et al., 2002c). NADP, glucose 6-phosphate, and glucose-6-phosphate dehydrogenase were purchased from Sigma-Aldrich (St. Louis, MO). Other reagents and chemicals used were 1049
2 1050 MIYAZWA ET AL. FIG. 1.HPLC analysis of the ( )-verbenone 10-hydroxylation by liver microsomes of human sample HL-J22 (A) and of PB-treated rats (B), and the dependence of incubation time (C) and protein concentration (D) on the formation of the hydroxylated metabolite was determined in liver microsomes of PB-treated rats. obtained from sources as described previously or were of the highest quality commercially available (Wang et al., 1980; Shimada et al., 1994, 2002a, 2002b; Miyazawa et al., 2002a,b). Enzymes and Antibodies. Human liver samples were obtained from organ donors or patients undergoing liver resection as described previously (Shimada et al., 1994, 1999). Liver microsomes were prepared as described and suspended in 10 mm Tris-HCl buffer (ph 7.4) containing 1.0 mm EDTA and 20% glycerol (v/v) (Guengerich, 1994; Shimada et al., 2002a). Recombinant CYP1A1, 1A2, 1B1, 2A6, 2B6, 2C8, 2C9, 2C18, 2C19, 2E1, and 3A4 expressed in T. ni infected with a baculovirus containing rat P450 and NADPH-P450 reductase cdna inserts were obtained from BD Gentest (Woburn, MA); the P450 contents in these systems were tested as described in the data sheets provided by the manufacturer. Male Sprague-Dawley rats (weighing about 200 g) obtained from Nihon Clea Co. (Osaka, Japan) were used throughout this study. Liver microsomes from untreated rats and rats treated with PB (80 mg/kg, daily for 3 days), -naphthoflavone (50 mg/kg, daily for 3 days), and pregnenolone 16 carbonitrile (80 mg/kg, daily for 3 days) were prepared as described and suspended in 10 mm Tris-HCl buffer (ph 7.4) containing 1.0 mm EDTA and 20% glycerol (v/v) (Guengerich, 1994; Shimada et al., 2002a). Rabbit antihuman CYP2A6 antibodies were prepared as described (Yun et al., 1991). HPLC Analysis of ( )-Verbenone 10-Hydroxylation. Standard incubation mixtures consisted of rat and human liver microsomes (0.10 mg of protein/ml) or recombinant rat and human P450s (10 pmol) and 200 M ( )-verbenone (dissolved in 2 l of dimethyl sulfoxide) in a final volume of 0.50 ml of 100 mm potassium phosphate buffer (ph 7.4) containing an NADPH-generating system (0.5 mm NADP, 5 mm glucose 6-phosphate, and 0.5 unit of glucose-6-phosphate dehydrogenase/ml). Incubations were carried out at 37 C for 20 min and terminated by adding 1.5 ml of CH 2 Cl 2. The mixture was mixed vigorously and centrifuged at 2,000 rpm for 4 min. The organic layer was evaporated to dryness under nitrogen atmosphere, and the residues were dissolved in small amounts of 40% methanol containing 20 mm NaClO 4 (ph 2.5). An aliquot (usually 25 l) of the extracts described above was used for HPLC analysis with a LC-CCPS system (Tosoh Co., Tokyo, Japan) with a spectrofluorometer (FS-8020; Tosoh Co.). Separation was done with a C m analytical column (Mightsil RP-18, mm; Kanto Chemical Co., Tokyo, Japan) equipped with a C m guard column (Mightsil RP-18, mm; Kanto Chemical Co.). The eluent consisted of a mixture of 40% methanol containing 20 mm NaClO 4 (ph 2.5). The flow rate was 1.0 ml/min, and the UV detection was done at 251 nm (Fig. 1). Peak areas thus obtained were integrated with a Chromatopac Instrument (C-R6A Chromatopac; Shimadzu, Kyoto, Japan). Other Assays. P450 and protein contents were estimated by the methods described elsewhere (Lowry et al., 1951; Omura and Sato, 1964). Statistical Analysis. Kinetic parameters for verbenone 10-hydroxylation by rat and human liver microsomes and recombinant rat and human P450s were estimated using a computer program (KaleidaGraph program from Synergy Software, Reading, PA) designed for nonlinear regression analysis of a hyperbolic Michaelis-Menten equation. Results HPLC Analysis of ( )-Verbenone 10-Hydroxylation by Liver Microsomes of Rats and Humans. ( )-Verbenone was incubated with liver microsomes of human sample HL-J22 and of rats treated with PB, and the products were extracted with dichloromethane and then analyzed with HPLC as described under Materials and Methods (Fig. 1). Human liver microsomes produced small amounts of 10- hydroxyverbenone (Fig. 1A), whereas liver microsomes of PB-treated rats formed ( )-verbenone at much higher rates (Fig. 1B). No other metabolites of ( )-verbenone were detected in these liver microsomes on analysis with HPLC. Formation of 10-hydroxyverbenone increased linearly with incubation time up to 20 min (Fig. 1C) and with liver microsomes of PB-treated rats up to 0.2 mg/ml of incubation (Fig. 1D). Role of Human CYP2A6 in the 10-Hydroxylation of ( )-Verbenone. Liver microsomes of 16 human samples were used for the determination of 10-hydroxylation of ( )-verbenone and 7-hydroxylation of coumarin, and correlation of theses activities was compared (Fig. 2). There was good correlation between these activities (r 0.89). Recombinant human P450 enzymes expressed in T. ni cells were tested for their catalytic activities to catalyze ( )-verbenone (Fig. 3). Among 10 human P450 enzymes determined so far, CYP2A6 and 2B6 were found to have the highest activities to hydroxylate ( )- verbenone at turnover rates of 18 and 16 nmol/min/nmol P450, respectively. Activities (nmol/min/nmol P450) with other recombi-
3 VERBENONE 10-HYDROXYLATION BY RAT AND HUMAN P450s 1051 FIG. 2.Correlation between ( )-verbenone 10-hydroxylation and coumarin 7- hydroxylation in liver microsomes of 16 human samples. FIG. 3.( )-Verbenone 10-hydroxylation by recombinant human P450 enzymes expressed in T. ni cells. Substrate concentration used was 200 M, and incubation time was 20 min. FIG. 4.Effects of anti-cyp2a6 IgG (A) and (R)-( )-menthofuran, coumarin, and thiotepa (B) on the ( )-verbenone 10-hydroxylation by liver microsomes of HL-J22, and the effects of methofuran on CYP2A6-dependent verbenone hydroxylation (C) and of thiotepa on CYP2B6-dependent verbenone hydroxylation (D) were also determined. FIG. 5.( )-Verbenone 10-hydroxylation by recombinant rat P450 enzymes expressed in T. ni cells. Other details are the same as in the legend to Fig. 3. nant human P450s were 0.39 for CYP3A4, 0.38 for CYP2D6, 0.28 for CYP2C9, 0.26 for CYP1A1, 0.19 for CYP1B1, 0.16 for CYP1A2, 0.09 for CYP2E1, and 0.02 for CYP2C19. Anti-CYP2A6 IgG significantly inhibited the ( )-verbenone 10- hydroxylation catalyzed by human liver microsomes, HL-J22 (Fig. 4A). (R)-( )-Menthofuran, an inhibitor of CYP2A6 (Khojasteh- Bakht et al., 1998), inhibited ( )-verbenone 10-hydroxylation catalyzed by human liver microsomes (Fig. 4B) and by recombinant CYP2A6 (Fig. 4C). Triethylenethiophosphoramide (thiotepa), an inhibitor of human CYP2B6 (Rae et al., 2002), inhibited ( )- verbenone 10-hydroxylation catalyzed by liver microsomes slightly (Fig. 4B) and by recombinant CYP2B6 significantly (Fig. 4D). Roles of Rat CYP2C11 and 2B1 in the 10-Hydroxylation of ( )-Verbenone. ( )-Verbenone 10-hydroxylation activities were determined in recombinant rat P450 enzymes expressed in T. ni cells (Fig. 5). CYP2B1 was the highest in the verbenone hydroxylation followed by CYP2C11, CYP2A2, and CYP3A1. Other rat P450s were very low in the 10-hydroxylation of ( )-verbenone. Particularly, female-specific CYP2C12 did not catalyze the hydroxylation at all. Kinetic Analysis of ( )-Verbenone 10-Hydroxylation by Human and Rat P450 Enzymes. Kinetic analysis of ( )-verbenone 10-hydroxylation catalyzed by liver microsomes of human HL-J22 and C12 showed that apparent K m values were 91 and 67 M, and V max values were 3.5 and 0.4 nmol/min/nmol P450, respectively (Table 1). The K m values of recombinant human CYP2A6 and 2B6 were 16 and 91 M, respectively. The ratio of V max and K m was about 4-fold higher in CYP2A6 than in CYP2B6. In the rat, the K m values of ( )-verbenone 10-hydroxylation by liver microsomes of untreated rats and of PB-treated rats were 198 and 61 M, respectively. Liver microsomes of rats treated with -naphthoflavone and pregnenolone-16 -carbonitrile had high K m values for ( )-verbenone 10-hydroxylation. The apparent K m value of recombinant CYP2B6 was lower than that of CYP2C11 in the verbenone 10-hydroxylation, and the K m values of CYP3A1 and 3A2 were 900 and 1850 M, respectively.
4 1052 MIYAZWA ET AL. TABLE 1 Kinetic analysis of the 10-hydroxylation of verbenone by rat and human liver microsomes and by recombinant rat and human P450 enzymes expressed in Trichoplusia ni cells Data are means of duplicate determinations and S.E.M. Enzyme K m V max V max /K m M nmol/min/nmol P450 ml/min/nmol P450 Human liver microsomes HL-J HL-C Recombinant human P450s CYP2A CYP2B Rat liver microsomes Male (untreated) Female (untreated) N.D. N.D. Male (PB-treated) Male (BNFtreated) Male (PCNtreated) Recombinant rat P450s CYP2B CYP2C CYP3A CYP3A N.D., not detectable; BNF, -naphthoflavone; PCN, pregnenolone 16 -carbonitrile. Discussion Our results showed that human and rat liver microsomes catalyze 10-hydroxylation of ( )-verbenone, a monoterpene bicyclic ketone and a component of the essential oil from rosemary species such as Rosmarinus officinalis L., Verbena triphylla, and Eucalyptus globulus (Ravid et al., 1997; Giorgio et al., 2002). CYP2A6 was identified to be a principal enzyme involved in the reaction in human liver microsomes with the following lines of evidence. First, there was good correlation between 10-hydroxylation of ( )-verbenone and 7-hydroxylation of coumarin, a typical substrate of CYP2A6 (Shimada et al., 1994; Pelkonen et al., 2000), in liver microsomes of 16 human samples. Second, anti-cyp2a6, coumarin, and (R)-( )-menthofuran significantly inhibited ( )-verbenone 10-hydroxylation by human liver microsomes. Third, recombinant human CYP2A6 expressed in T. ni cells had very high turnover rates in the hydroxylation of ( )-verbenone. Finally, the efficiency of catalysis (V max /K m value) of CYP2A6 was found to be 4-fold higher than that of CYP2B6, having apparent K m values for CYP2A6 and 2B6 of 16 and 91 M, respectively. Although recombinant CYP2B6 had a high turnover rate for ( )-verbenone 10-hydroxylation, the contribution of this enzyme in FIG. 6.Metabolism of ( )-verbenone, 1,4-cineole, 1,8-cineole, and ( )-limonene by human and rat P450 enzymes.
5 VERBENONE 10-HYDROXYLATION BY RAT AND HUMAN P450s 1053 human liver microsomes may be minor, due to the fact that CYP2B6 has been shown to be present at low levels in liver microsomes of human samples (Shimada et al., 1994). There were clear species-related differences in the metabolism of ( )-verbenone by liver microsomes of humans and rats. As described above, human CYP2A6 was a major enzyme, and CYP2B6 was catalyzed partially in the 10-hydroxylation of ( )-verbenone by liver microsomes. In contrast, rat CYP2A1 and 2A2 were devoid of catalytic activities in rat liver microsomes. Such differences in the catalytic roles of CYP2A enzymes in rats and humans have already been reported in the metabolism of testosterone and coumarin (Yamazaki et al., 1994; Pelkonen et al., 2000). Human CYP2A6 catalyzed coumarin hydroxylation at high rates, whereas rat CYP2A enzymes did not (Yamazaki et al., 1994). It has also been reported that testosterone is catalyzed by rat CYP2A enzymes at the 7 -position, although human CYP2A6 does not catalyze this reaction (Yamazaki et al., 1994). Thus the present results suggest that ( )-verbenone is another substrate that shows differences in the metabolism in rat and human CYP2A enzymes. However, it remains unclear whether such species-related differences in the metabolism of ( )-limonene by CYP2A enzymes affect the biological and toxicological activities of this monoterpene compound in rats and humans. Species-related differences were also noted in the catalytic roles of rat and human CYP2C enzymes in the 10-hydroxylation of ( )- verbenone in liver microsomes. Rat CYP2C11 catalyzed ( )-verbenone 10-hydroxylation at a rate of 10 nmol/min/nmol P450, whereas human CYP2C9 and 2C19 had turnover rates of 0.28 and 0.02 nmol/min/nmol P450, respectively. In addition, our present results showed that there were sex-related differences in the roles of rat CYP2C enzymes in the ( )-verbenone 10-hydroxylation, in that female-specific CYP2C12 did not catalyze this reaction. Our recent studies have also shown that male rat-specific CYP2C11, but not female rat-specific CYP2C12, metabolizes ( )- and ( )-limonene enantiomers, monoterpene cyclic ethers, in liver microsomes (Miyazawa et al., 2001a,b, 2002b). Collectively, these studies are of interest, since it has been suggested that CYP2C family enzymes are considered to be diversely developed by catalyzing a variety of lipophilic compounds to inert and polar metabolites, when these are ingested through foods and air (Nebert and Gonzalez, 1987; Gonzalez, 1990). We have previously reported that 1,4-cineole, 1,8-cineole, and ( )- and ( )-limonene enantiomers, monoterpene compounds present in nature, are metabolized by different forms of P450 enzymes in several animal species including rats and humans (Fig. 6) (Miyazawa et al., 2001a,b; 2002b). 1,4-Cineole and 1,8-cineole are both principally oxidized at the 2-position by CYP3A4 in humans and CYP3A1/2 in rats, and it has also been shown that 1,4-cineole is partially catalyzed by CYP2A6 in humans (Miyazawa et al., 2001a,b). The role of CYP2A6 in the oxidation of 1,8-cineole has been reported to be minor (Miyazawa et al., 2001b). ( )- and ( )-Limonenes are metabolized by liver microsomes to form respective carveols and perillyl alcohols by CYP2C9 and 2C19 in humans and CYP2C11 in rats (Miyazawa et al., 2002b; Shimada et al., 2002b). Interestingly, rat CYP2B1 has high catalytic rates for the metabolism of ( )- and ( )-limonene enantiomers, whereas the orthologous human enzyme, CYP2B6, does not oxidize limonene metabolism capacity at all (Miyazawa et al., 2002b; Shimada et al., 2002b). These results collectively indicated that natural terpene compounds in the environment are differentially oxidized by different P450 enzymes in several animal species and that the structures of these chemicals determine which molecules are attacked by P450 enzymes (Korzekwa and Jones, 1993; Lewis, 1998; Dai et al., 2000). Further work will be required to determine how these terpene compounds cause biological and toxicological responses in animal species, including humans. In conclusion, the present results showed that ( )-verbenone, a monoterpene bicyclic ketone, was catalyzed by P450 enzymes to form 10-hydroxylated verbenone in human and rat liver microsomes. Human CYP2A6 had the highest rate in the ( )-verbenone 10-hydroxylation, followed by CYP2B6 in human liver microsomes. In the rat, although CYP2A1/2 was inactive in catalyzing verbenone hydroxylation, CYP2C11, a male-specific enzyme, was a major catalyst in untreated male rats. Female-specific CYP2C12 did not catalyze verbenone 10-hydroxylation at a significant rate. Rat CYP2B1 was a major enzyme in the metabolism of verbenone in liver microsomes of PB-treated rats. References Dai R, Pincus MR, and Friedman FK (2000) Molecular modeling of mammalian cytochrome P450s. Cell Mol Life Sci 57: Giorgio P, Marianna U, Pascale B, Claudia J, Felix T, Mario C, Riccardo C, and Joseph C (2002) Chemical composition and antimicrobial activity of Rosemarinus officinalis L. oil from Sardinia and Corsica. Folia Pharmacol Jpn 17: Gonzalez FJ (1990) Molecular genetics of the P-450 superfamily. Pharmacol Ther 45:1 38. Guengerich FP (1994) Analysis and characterization of enzymes, in Principles and Methods of Toxicology (Hayes AW ed) pp , Raven Press, New York. Khojasteh-Bakht SC, Koenigs LL, Peter RM, Trager WF, and Nelson SD (1998) (R)-( )- Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6. Drug Metab Dispos 26: Korzekwa KR and Jones JP (1993) Predicting the cytochrome P450 mediated metabolism of xenobiotics. Pharmacogenetics 3:1 18. Lewis DFV (1998) The CYP2 family: models, mutants and interactions. Xenobiotica 28: Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: Miyazawa M, Shindo M, and Shimada T (2001a) Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from Eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos 29: Miyazawa M, Shindo M, and Shimada T (2001b) Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, the monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica 31: Miyazawa M, Shindo M, and Shimada T (2002a) Sex differences in the metabolism of ( )- and ( )-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome P450 enzymes in rat liver microsomes. Chem Res Toxicol 15: Miyazawa M, Shindo M, and Shimada T (2002b) Metabolism of ( )- and ( )-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos 30: Miyazawa M, Sugie A, and Shindo M (2002c) Biotransformation of ( )-verbenone by human liver microsomes. Biosci Biotechnol Biochem 66: Nebert DW and Gonzalez FJ (1987) P450 genes: structure, evolution and regulation. Annu Rev Biochem 56: Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: Pelkonen O, Rautio A, Raunio H, and Pasanen M (2000) CYP2A6: a human coumarin 7-hydroxylase. Toxicology 144: Rae JM, Soukhova NV, Flockhart DA, and Desta Z (2002) Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism. Drug Metab Dispos 30: Ravid U, Putievsky E, Katzir I, Lewinsohn E, and Dudai N (1997) Identification of (1R)( )- verbenone in essential oils of Rosmarinus officinalis L. Flavour Fragr J 12: Shimada T, Inoue K, Suzuki Y, Kawai T, Azuma E, Nakajima T, Shindo M, Kurose K, Sugie A, Yamagishi Y, et al. (2002a) Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis 23: Shimada T, Shindo M, and Miyazawa M (2002b) Species differences in the metabolism of ( )- and ( )-limonenes and their metabolites, carveols and carvones, by cytochrome P450 enzymes in liver microsomes of mice, rats, guinea pigs, henoba, dogs, monkeys and humans. Drug Metab Pharmacokinet 17: Shimada T, Tsumura F, and Yamazaki H (1999) Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone using kinetic parameters of recombinant cytochrome P450 enzymes. Drug Metab Dispos 27: Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: Wang P, Mason PS, and Guengerich FP (1980) Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver. Arch Biochem Biophys 199: Yamazaki H, Mimura M, Sugahara C, and Shimada T (1994) Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7 - and coumarin 7-hydroxylations. Biochem Pharmacol 48: Yun CH, Shimada T, and Guengerich FP (1991) Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:
METABOLISM OF ( )- AND ( )-LIMONENES TO RESPECTIVE CARVEOLS AND PERILLYL ALCOHOLS BY CYP2C9 AND CYP2C19 IN HUMAN LIVER MICROSOMES
0090-9556/02/3005-602 607$7.00 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 5 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 641/981193 DMD 30:602 607, 2002 Printed
More informationINVOLVEMENT OF CYP2E1 AS A LOW-AFFINITY ENZYME IN PHENACETIN O-DEETHYLATION IN HUMAN LIVER MICROSOMES
0090-9556/99/2708-0860 865$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 8 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. INVOLVEMENT OF
More informationArena Pharmaceuticals, Inc., Department of Drug Metabolism and Pharmacokinetics, San Diego, California
1521-009X/12/4004-761 771$25.00 DRUG METABOLISM AND DISPOSITION Vol. 40, No. 4 Copyright 2012 by The American Society for Pharmacology and Experimental Therapeutics 43414/3759637 DMD 40:761 771, 2012 Identification
More informationRat cytochrome P450 2C11 in liver microsomes involved in oxidation of. anesthetic agent propofol and deactivated by prior treatment with
DMD Fast This article Forward. has not been Published copyedited on and August formatted. 8, The 2006 final version as doi:10.1124/dmd.106.011627 may differ from this version. Rat cytochrome P450 2C11
More informationReceived May 30, 2007; accepted August 15, 2007
0090-9556/07/3511-1990 1995$20.00 DRUG METABOLISM AND DISPOSITION Vol. 35, No. 11 Copyright 2007 by The American Society for Pharmacology and Experimental Therapeutics 16816/3267964 DMD 35:1990 1995, 2007
More informationXTreme 200 Human Liver Microsomes Lot No Human Liver Microsomes Pool of 200 (100 Male and 100 Female) Suspension medium: 250 mm sucrose
XTreme 200 Human Liver Microsomes Lot No. 1710084 Human Liver Microsomes Pool of 200 (100 Male and 100 Female) Suspension medium: 250 mm sucrose H2610 0.5 ml at 20 mg/ml H2620 1.0 ml at 20 mg/ml H2630
More informationMetabolism and metabolic inhibition of cilnidipine in human liver microsomes 1
263 2003, Acta Pharmacologica Sinica Chinese Pharmacological Society Shanghai Institute of Materia Medica Chinese Academy of Sciences http://www.chinaphar.com Metabolism and metabolic inhibition of cilnidipine
More informationIn vitro metabolism of montelukast by Cytochrome P450s (CYPs) and UDPglucuronosyltransferases
In vitro metabolism of montelukast by Cytochrome P450s (CYPs) and UDPglucuronosyltransferases (UGTs) Josiane de Oliveira Cardoso, Regina Vincenzi Oliveira, Jessica Bo Li Lu Zeruesenay Desta Department
More informationENHANCEMENT OF CYTOCHROME P-450 3A4 CATALYTIC ACTIVITIES BY CYTOCHROME b 5 IN BACTERIAL MEMBRANES
0090-9556/99/2709-0999 1004$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 9 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. ENHANCEMENT OF
More informationBIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL DIFFERENTIAL INHIBITION OF AFLATOXIN B1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER MICROSOMES
Vol. 43, No. 4, November 1997 Pages 839-846 DIFFERENTIAL INHIBITION OF AFLATOXIN B1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER MICROSOMES Bok Ryang Kim,* Hyun Sook Oh,** and Dong-Hyun Kim ~t'l *Department
More informationAND LIVER MICROSOMAL P-450 PROFILES
0090-9556/99/2706-0655 666$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 6 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. DEVELOPMENT OF
More informationDifferential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes
Differential selectivity of cytochrome P4 inhibitors against probe substrates in human and rat liver microsomes Victoria A. Eagling, John F. Tjia & David J. Back Department of Pharmacology & Therapeutics,
More informationCytochrome P450 enzymes are involved in the metabolism of foreign substances
KHAN, MOHAMMAD MAZAMAL, M.S. Inhibition of Cytochrome P450 2E1 and Cytochrome P450 2A6 by Essential Oils: Tarragon (Artemisia dracunculus) and Basil (Ocimum basilicum). (2014) Directed by Dr. Gregory M.
More informationHIROSHI YAMAZAKI, KIYOSHI INOUE, PETER M. SHAW, WILLIAM J. CHECOVICH, F. PETER GUENGERICH and TSUTOMU SHIMADA
0022-3565/97/2832-0434$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 283, No. 2 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationSorafenib (free base, >99%) was obtained from Chemie Tek (Indianapolis, IN), and
Supplemental Methods Chemicals and Reagents Sorafenib (free base, >99%) was obtained from Chemie Tek (Indianapolis, IN), and isotopically-labeled 13 C- 2 H 3 -sorafenib (labeled atoms on N-methyl position)
More informationDAPSONE ACTIVATION OF CYP2C9-MEDIATED METABOLISM: EVIDENCE FOR ACTIVATION OF MULTIPLE SUBSTRATES AND A TWO-SITE MODEL
0090-9556/01/2907-1029 1034$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 7 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 352/914007 DMD 29:1029 1034, 2001 Printed
More informationIN VITRO BIOTRANSFORMATION OF SILDENAFIL (VIAGRA): IDENTIFICATION OF HUMAN CYTOCHROMES AND POTENTIAL DRUG INTERACTIONS
0090-9556/00/2804-0392 397$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 28, No. 4 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. IN VITRO BIOTRANSFORMATION
More informationIsolation and Purification of Organic Compounds Steam Distillation of Essential Oils
Isolation and Purification of Organic Compounds Steam Distillation of Essential Oils Distillation relies on the fact that the substance with the greatest vapor pressure will be enriched in the vapor phase
More informationDRUG INTERACTION BETWEEN SIMVASTATIN AND ITRACONAZOLE IN MALE AND FEMALE RATS
0090-9556/01/2907-1068 1072$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 7 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 331/915884 DMD 29:1068 1072, 2001 Printed
More informationTitle. YOON, Seokjoo; MARUYAMA, Yutaka; KA FUJITA, Shoichi. Author(s) Issue Date /jjvr
Title Application of FT-IR and ESR spectr study of CCl_4-induced peroxidation Author(s) YOON, Seokjoo; MARUYAMA, Yutaka; KA FUJITA, Shoichi Citation Japanese Journal of Veterinary Rese Issue Date 2000-02-29
More informationEffective NADH-Dependent Oxidation of 7b -Hydroxy-D 8 - tetrahydrocannabinol to the Corresponding Ketone by Japanese Monkey Hepatic Microsomes
646 Biol. Pharm. Bull. 28(4) 646 651 (2005) Vol. 28, No. 4 Effective NADH-Dependent Oxidation of 7b -Hydroxy-D 8 - tetrahydrocannabinol to the Corresponding Ketone by Japanese Monkey Hepatic Microsomes
More informationBIOSYNTHESIS OF ALL-TRANS-RETINOIC ACID FROM ALL-TRANS-RETINOL: CATALYSIS OF ALL-TRANS-RETINOL OXIDATION BY HUMAN P-450 CYTOCHROMES
0090-9556/00/2803-0315 322$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 28, No. 3 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. BIOSYNTHESIS OF
More informationFORMATION OF A DIHYDROXY METABOLITE OF PHENYTOIN IN HUMAN LIVER MICROSOMES/CYTOSOL: ROLES OF CYTOCHROMES P450 2C9, 2C19, AND 3A4
0090-9556/00/2811-1361 1368$03.00/0 DRUG METABOLISM AND DISPOSITION Vol. 28, No. 11 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics 63/859475 DMD 28:1361 1368, 2000
More informationNaoya Takahashi, Keiya Hirota and Yoshitaka Saga* Supplementary material
Supplementary material Facile transformation of the five-membered exocyclic E-ring in 13 2 -demethoxycarbonyl chlorophyll derivatives by molecular oxygen with titanium oxide in the dark Naoya Takahashi,
More informationShort Communication. Received June 13, 2004; accepted November 10, 2004
0090-9556/05/3302-214 218$20.00 DRUG METABOLISM AND DISPOSITION Vol. 33, No. 2 Copyright 2005 by The American Society for Pharmacology and Experimental Therapeutics 984/1194711 DMD 33:214 218, 2005 Printed
More informationCharacterization of human cytochrome P-450 enzymes involved in the metabolism of. the piperidine-type phenothiazine neuroleptic thioridazine
DMD Fast This Forward. article has not Published been copyedited on and November formatted. The 4, final 2005 version as doi:10.1124/dmd.105.006445 may differ from this version. DMD #6445 Characterization
More informationLarge interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity
et al. DOI:1.146/j.1365-2125.3.197.x British Journal of Clinical Pharmacology Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity
More informationPilot experiments to investigate the glucuronidation of axitinib with human liver microsomes.
Zientek MA, Goosen TC, Tseng E, Lin J, Bauman JN, Walker GS, Kang P, Jiang Y, Freiwald S, Neul D and Smith BJ. In Vitro Kinetic Characterization of Axitinib Metabolism. Drug Metab Dispos. Supplemental
More informationThe influence of bile acids homeostasis by cryptotanshinone-containing herbs
The influence of bile acids homeostasis by cryptotanshinone-containing herbs Chengcheng Gao, Tianheng Ma, Liqun Pang, Rui Xie* Department of Gastroenterology, Huai an First People s Hospital, Nanjing Medical
More informationSUPPORTING INFORMATION
SUPPORTING INFORMATION Reduction of Aromatic and Heterocyclic Aromatic N-Hydroxylamines by Human Cytochrome P450 2S1 Wang, K., and Guengerich, F. P. (2013) Chem. Res. Toxicol. 26, 000-000 Figure S1. HPLC
More informationKit for assay of thioredoxin
FkTRX-02-V2 Kit for assay of thioredoxin The thioredoxin system is the major protein disulfide reductase in cells and comprises thioredoxin, thioredoxin reductase and NADPH (1). Thioredoxin systems are
More informationPolychlorinated Biphenyls: A New Type of Inducer of Cytochrome
Proc. Nat. Acad. Sci. USA Vol. 7, No. 5, pp. 1321-1325, May 1973 Polychlorinated Biphenyls: A New Type of nducer of Cytochrome P-448 in the Liver (cytochrome P-45/rats aryl hydrocarbon hydroxylase/enzyme
More informationIN VITRO IDENTIFICATION OF THE HUMAN CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF R( )- AND S( )-CARVEDILOL
0090-9556/97/2508-0970 977$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 25, No. 8 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. IN VITRO IDENTIFICATION
More informationReceived December 14, 2009; accepted March 19, 2010
0090-9556/10/3807-1211 1217$20.00 DRUG METABOLISM AND DISPOSITION Vol. 38, No. 7 Copyright 2010 by The American Society for Pharmacology and Experimental Therapeutics 31625/3591857 DMD 38:1211 1217, 2010
More informationSTEREOSELECTIVE METABOLISM OF LANSOPRAZOLE BY HUMAN LIVER CYTOCHROME P450 ENZYMES
0090-9556/03/3110-1227 1234$7.00 DRUG METABOLISM AND DISPOSITION Vol. 31, No. 10 Copyright 2003 by The American Society for Pharmacology and Experimental Therapeutics 1086/1095069 DMD 31:1227 1234, 2003
More informationName: Student Number
UNIVERSITY OF GUELPH CHEM 454 ENZYMOLOGY Winter 2003 Quiz #1: February 13, 2003, 11:30 13:00 Instructor: Prof R. Merrill Instructions: Time allowed = 80 minutes. Total marks = 34. This quiz represents
More informationHuman cytochrome P450 mono-oxygenase system is suppressed by propofol
British Journal of Anaesthesia 1995; 74: 558-562 Human cytochrome P450 mono-oxygenase system is suppressed by propofol T. L. CHEN, T. H. UENG, S. H. CHEN, P. H. LEE, S. Z. FAN AND C. C. LIU Summary We
More informationKARTHIK VENKATAKRISHNAN, LISA L. VON MOLTKE, and DAVID J. GREENBLATT
0022-3565/01/2971-326 337$3.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 297, No. 1 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 3324/893791
More informationSupplementary Data. Supplementary Materials and Methods Measurement of NO formation by ozone-based chemiluminescence. Supplementary References
Supplementary Data Supplementary Materials and Methods Measurement of NO formation by ozone-based chemiluminescence Nitric oxide (NO) production was measured by ozonebased chemiluminescence using a Sievers
More informationTSUTOMU SHIMADA, YOSHIMITSU ODA, ELIZABETH M. J. GILLAM, F. PETER GUENGERICH, AND KIYOSHI INOUE
0090-9556/01/2909-1176 1182$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 9 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 403/923026 DMD 29:1176 1182, 2001 Printed
More informationInvolvement of CYP2C8 and UGT1A9 in the metabolism of a novel gastroprokinetic agent, Z-338
Involvement of CYP2C8 and UGT1A9 in the metabolism of a novel gastroprokinetic agent, Z-338 S. Furuta 1, E. Kamada 1, T. Sugimoto 1, Y. Kawabata 1, X. C. Wu 2, J. Skibbe 3, E. Usuki 3, A. Parkinson 3 and
More informationStereoselective Metabolism of Bufuralol Racemate and Enantiomers in Human Liver Microsomes
0022-3565/02/3031-172 178$7.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 303, No. 1 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 36533/1006673
More informationCYTOCHROME P450: Structure-Function
MEDCH 527 AE Jan. 4-6, 2017 CYTCHME P450: Structure-Function 1. General P450 Characteristics and Taxonomy 2. Human P450s Substrate and Inhibitor Selectivities 3. Structure-Function Aspects of Ligand Binding,
More informationMetabolism of 3 -Carene by Human Cytochrome P450 Enzymes: Identification and Characterization of Two New Metabolites
Current Drug Metabolism, 2005, 6, 593-601 593 Metabolism of 3 -Carene by Human Cytochrome P450 Enzymes: Identification and Characterization of Two New Metabolites Mike Duisken a, Dorina Benz a, Thomas
More informationVALIDATION OF BUPROPION HYDROXYLATION AS A SELECTIVE MARKER OF HUMAN CYTOCHROME P450 2B6 CATALYTIC ACTIVITY
0090-9556/00/2810-1222 1230$03.00/0 DRUG METABOLISM AND DISPOSITION Vol. 28, No. 10 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics 163/855917 DMD 28:1222 1230, 2000
More informationRole of Human Liver Microsomal CYP3A4 and CYP2B6 in Catalyzing N-Dechloroethylation of Cyclophosphamide and Ifosfamide
Biochemical Pharmacology, Vol. 59, pp. 961 972, 2000. ISSN 0006-2952/00/$ see front matter 2000 Elsevier Science Inc. All rights reserved. PII S0006-2952(99)00410-4 Role of Human Liver Microsomal CYP3A4
More informationB. Incorrect! Compounds are made more polar, to increase their excretion.
Pharmacology - Problem Drill 04: Biotransformation Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What is biotransformation?
More informationA biocatalytic hydrogenation of carboxylic acids
Electronic Supplementary Information (ESI) for: A biocatalytic hydrogenation of carboxylic acids Yan Ni, Peter-Leon Hagedoorn,* Jian-He Xu, Isabel Arends, Frank Hollmann* 1. General Chemicals All the carboxylic
More informationBIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL Pages 48]-486
Vol. 41, No. 3, March 1997 BIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL Pages 48]-486 INACTIVATION OF ACONITASE IN YEAST EXPOSED TO OXIDATIVE STRESS Keiko Murakami and Masataka Yoshino* Department
More informationMETABOLISM AND NUTRITION. Comparative metabolism of warfarin in rats and chickens
METABOLISM AND NUTRITION Comparative metabolism of warfarin in rats and chickens A. Saengtienchai, Y. Ikenaka, K. Watanabe, T. Ishida, and M. Ishizuka1 Department of Environmental Veterinary Sciences,
More informationCytochrome P450 Drug Interaction Table Flockhart Table
Cytochrome P450 Drug Interaction Table Flockhart Table The table contains lists of drugs in columns under the designation of specific cytochrome P450 isoforms. CYTOCHROME P450 DRUG INTERACTION TABLE A
More informationCATALYTIC SPECIFICITY OF CYP2D ISOFORMS IN RAT AND HUMAN
0090-9556/02/3009-970 976$7.00 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 9 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 696/1004051 DMD 30:970 976, 2002 Printed
More informationMetabolism of the active metabolite of quetiapine, N-desalkylquetiapine, in
DMD Fast This article Forward. has not been Published copyedited on and June formatted. 11, The 2012 final version as doi:10.1124/dmd.112.045237 may differ from this version. Metabolism of the active metabolite
More informationSupplementary Material
Supplementary Material Antimicrobial mechanism of theaflavins: They target 1-deoxy-D-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway Xian Hui, Qiao Yue,
More informationMODULE No.26: Drug Metabolism
SUBJECT Paper No. and Title Module No. and Title Module Tag PAPER No. 9: Drugs of Abuse MODULE No. 26: Drug Metabolism FSC_P9_M26 TABLE OF CONTENTS 1. Learning Outcomes 2. Introduction 3. Sites of Drug
More informationROLE OF CYTOCHROME P-4502C9 IN IRBESARTAN OXIDATION BY HUMAN LIVER MICROSOMES
0090-9556/99/2702-0288 296$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 2 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. ROLE OF CYTOCHROME
More informationThiol-Activated gem-dithiols: A New Class of Controllable. Hydrogen Sulfide (H 2 S) Donors
Thiol-Activated gem-dithiols: A New Class of Controllable Hydrogen Sulfide (H 2 S) Donors Yu Zhao, Jianming Kang, Chung-Min Park, Powell E. Bagdon, Bo Peng, and Ming Xian * Department of Chemistry, Washington
More informationPathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine S
Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2008/05/07/dmd.107.019562.dc1 0090-9556/08/3608-1637 1649$20.00 DRUG METABOLISM AND DISPOSITION Vol. 36,
More informationSupporting information
Electronic Supplementary Material (ESI) for Nanoscale. This journal is The Royal Society of Chemistry 2014 Supporting information Seeing the Diabetes: Visual Detection of Glucose Based on the Intrinsic
More informationEnantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes
Enantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes Ikuo Yamamiya 1,2, Kunihiro Yoshisue 1, Yuji Ishii 2, Hideyuki Yamada 2 & Ken-ichiro
More informationOpinion on. Classification of Musk ketone
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER
More informationChapter 9. Biotransformation
Chapter 9 Biotransformation Biotransformation The term biotransformation is the sum of all chemical processes of the body that modify endogenous or exogenous chemicals. Focus areas of toxicokinetics: Biotransformation
More informationMETABOLISM OF (R)-( )-PULEGONE AND (R)-( )-MENTHOFURAN BY HUMAN LIVER CYTOCHROME P-450s: EVIDENCE FOR FORMATION OF A FURAN EPOXIDE
0090-9556/99/2705-0574 580$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 5 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. METABOLISM OF (R)-(
More informationShort Communication FORMATION OF N-ALKYLPROTOPORPHYRIN IX FROM METABOLISM OF DIALLYL SULFONE IN LUNG AND LIVER
0090-9556/06/3406-895 900$20.00 DRUG METABOLISM AND DISPOSITION Vol. 34, No. 6 Copyright 2006 by The American Society for Pharmacology and Experimental Therapeutics 9928/3113435 DMD 34:895 900, 2006 Printed
More informationSUPPLEMENTARY DATA. Materials and Methods
SUPPLEMENTARY DATA Materials and Methods HPLC-UV of phospholipid classes and HETE isomer determination. Fractionation of platelet lipid classes was undertaken on a Spherisorb S5W 150 x 4.6 mm column (Waters
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION DOI: 10.1038/NNANO.2012.80 Protein-Inorganic Hybrid Nanoflowers Jun Ge, Jiandu Lei, and Richard N. Zare Supporting Online Material Materials Proteins including albumin from bovine
More informationMetabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma 2015 年 下川義彦 Table of Contents List of Abbreviations Chapter 1 General Introduction 1 Chapter 2 In Vivo Pharmacokinetics and
More informationCYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
0090-9556/05/3312-1811 1818$20.00 DRUG METABOLISM AND DISPOSITION Vol. 33, No. 12 Copyright 2005 by The American Society for Pharmacology and Experimental Therapeutics 6254/3063240 DMD 33:1811 1818, 2005
More informationINHIBITION OF PHENYLALANINE HYDROXYLASE, A PTERIN-REQUIRING MONOOXYGENASE, BY AND ITS DERIVATIVES
458 THE JOURNAL OF ANTIBIOTICS APR. 1982 INHIBITION OF PHENYLALANINE HYDROXYLASE, A PTERIN-REQUIRING MONOOXYGENASE, BY OUDENONE AND ITS DERIVATIVES SHINICHI KOIZUMI, TOSHIHARU NAGATSU, HIRONOBU IINUMA*,
More informationChapter 4. Drug Biotransformation
Chapter 4 Drug Biotransformation Drug Biotransformation 1 Why is drug biotransformation necessary 2 The role of biotransformation in drug disposition 3 Where do drug biotransformation occur 4 The enzymes
More informationANTHONY J. LEE, JOSEPH W. KOSH, ALLAN H. CONNEY, 1 and BAO TING ZHU. ABSTRACT We characterized the NADPH-dependent metabolism of 17 estradiol
0022-3565/01/2982-420 432$3.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 298, No. 2 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 3751/916932
More informationScreening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System
Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System Ohtsuji M, Ohshima T, Takayasu T, Nishigami J, Kondo T, Lin Z, Minamino T Department of Legal Medicine,
More informationDetermination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography
Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography Application ote Food Safety Authors Chen-Hao Zhai and Yun Zou Agilent Technologies Co. Ltd.
More informationMechanism-Based Inhibition of CYP3A4 by Constituents of Zingiber aromaticum
March 2005 Biol. Pharm. Bull. 28(3) 495 499 (2005) 495 Mechanism-Based Inhibition of CYP3A4 by Constituents of Zingiber aromaticum Tepy USIA, a Tadashi WATABE, a Shigetoshi KADOTA, a and Yasuhiro TEZUKA*,a,b
More informationCYTOCHROME P-450 3A4 AND 2C8 ARE INVOLVED IN ZOPICLONE METABOLISM
0090-9556/99/2709-1068 1073$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 9 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. CYTOCHROME P-450
More informationPrilocaine- and Lidocaine-induced Methemoglobinemia is Caused by Human. Carboxylesterase-, CYP2E1- and CYP3A4-mediated Metabolic Activation
DMD Fast This article Forward. has not been Published copyedited on and March formatted. 25, The 2013 final version as doi:10.1124/dmd.113.051714 may differ from this version. Prilocaine- and Lidocaine-induced
More informationSUPPLEMENTAL INFORMATION
SUPPLEMENTAL INFORMATION EXPERIMENTAL PROCEDURES Tryptic digestion protection experiments - PCSK9 with Ab-3D5 (1:1 molar ratio) in 50 mm Tris, ph 8.0, 150 mm NaCl was incubated overnight at 4 o C. The
More informationStereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 49-OH-bupropion in vitro
1521-009X/44/10/1709 1719$25.00 http://dx.doi.org/10.1124/dmd.116.072363 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 44:1709 1719, October 2016 Copyright ª 2016 by The Author(s) This is an open access
More informationIdentification of ginkgolide B metabolites in urine and rat liver cytochrome P450 enzymes responsible for their formation in vitro 1
Acta Pharmacol Sin 2008 Mar; 29 (3): 376 384 Full-length article Identification of ginkgolide B metabolites in urine and rat liver cytochrome P450 enzymes responsible for their formation in vitro 1 Dian-lei
More informationIn silico prediction of metabolism as a tool to identify new metabolites of dietary monoterpenes
In silico prediction of metabolism as a tool to identify new metabolites of dietary monoterpenes Jarlei Fiamoncini Food Metabolome and the Metabolism of Food Compounds Food metabolome is the part of the
More informationThe metabolism of 1 - and 4-hydroxymidazolam by glucuronide conjugation is. largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7
DMD Fast This article Forward. has not Published been copyedited on and August formatted. 16, The 2010 final version as doi:10.1124/dmd.110.035295 may differ from this version. The metabolism of 1 - and
More informationMethadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)
DMD This Fast article Forward. has not been Published copyedited on and formatted. April 21, The 2010 final as version doi:10.1124/dmd.110.032474 may differ from this version. DMD #32474 Methadone: A Substrate
More informationMETABOLISM OF DRUGS BY SUBFRACTIONS OF HEPATIC MICROSOMES FROM PROLONGED ETHANOL-TREATED RATS
METABOLISM OF DRUGS BY SUBFRACTIONS OF HEPATIC MICROSOMES FROM PROLONGED ETHANOL-TREATED RATS Suehiro NAKANISHI, Go KINOSHITA, Eiko SHIOHARA and Miyoko TSUKADA Department of Pharmacology, Faculty of Medicine,
More informationShort Communication. Abstract. Introduction
Short Communication JPP, 6: 76 7 The Authors JPP Royal Pharmaceutical Society Received November 8, Accepted February, DOI./j.-758..76.x ISSN -57 Relationship between lipophilicity and absorption from the
More informationAn Investigative Study of Reactions Involving Glucosinolates and Isothiocyanates
An Investigative Study of Reactions Involving Glucosinolates and Isothiocyanates Alzea Chrisel H. Alea 1, Diane Elaine T. Co 2 and Marissa G Noel 3* 1,2,3Chemistry Department, De La Salle University, 2401
More informationEVALUATION OF CYTOCHROME P450 PROBE SUBSTRATES COMMONLY USED BY THE PHARMACEUTICAL INDUSTRY TO STUDY IN VITRO DRUG INTERACTIONS
0090-9556/02/3012-1311 1319 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 12 U.S. Government work not protected by U.S. copyright 548/1028208 DMD 30:1311 1319, 2002 Printed in U.S.A. EVALUATION OF CYTOCHROME
More informationMECHANISM-BASED INACTIVATION OF CYP2C11 BY DICLOFENAC
0090-9556/01/2909-1190 1195$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 9 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 400/923028 DMD 29:1190 1195, 2001 Printed
More informationIn vitro metabolism of corydaline in human liver microsomes and hepatocytes using liquid chromatography-ion trap mass spectrometry
1102 J. Sep. Sci. 2012, 35, 1102 1109 Hye Young Ji 1 Hyeri Lee 1,2 Jeong-Han Kim 2 Ki Hyun Kim 3 Kang Ro Lee 3 Hyun Joo Shim 4 Miwon Son 4 Hye Suk Lee 1 1 Drug Metabolism & Bioanalysis Laboratory, College
More informationTitle: Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib
Title: Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib Joanna K. Towles, Rebecca N. Clark, Michelle D. Wahlin, Vinita Uttamsingh, Allan E. Rettie, and Klarissa Hardy Jackson Department
More informationMetabolism of 1 - and 4-Hydroxymidazolam by Glucuronide Conjugation Is Largely Mediated by UDP-Glucuronosyltransferases 1A4, 2B4, and 2B7
0090-9556/10/3811-2007 2013$20.00 DRUG METABOLISM AND DISPOSITION Vol. 38, No. 11 Copyright 2010 by The American Society for Pharmacology and Experimental Therapeutics 35295/3635725 DMD 38:2007 2013, 2010
More informationInhibition studies of Cytochrome P450 2A6 by Vernonia cinerea Less and Carthamas tinctorius L. extracts
Inhibition studies of Cytochrome P450 2A6 by Vernonia cinerea Less and Carthamas tinctorius L. extracts Tunyaporn Wongsri a,b, Sarinya Thongjam b, Pornpimol Rongnoparut c, Panida Duangkaew d, Songklod
More informationAutoinduction of the metabolism of phenothiazine neuroleptics in a primary culture of human hepatocytes
Pharmacological Reports 2012, 64, 1578 1583 ISSN 1734-1140 Copyright 2012 by Institute of Pharmacology Polish Academy of Sciences Short communication Autoinduction of the metabolism of phenothiazine neuroleptics
More informationInteraction of lanthanum chloride with human erythrocyte membrane in relation to acetylcholinesterase activity
J. Biosci., Vol. 13, Number 2, June 1988, pp. 123 128. Printed in India. Interaction of lanthanum chloride with human erythrocyte membrane in relation to acetylcholinesterase activity SUNIL MUKHOPADHYAY,
More informationElectronic Supplementary Information. Table of Contents
Electronic Supplementary Information Examination of native chemical ligation using peptidyl prolyl thioester Takahiro Nakamura, Akira Shigenaga, Kohei Sato, Yusuke Tsuda, Ken Sakamoto, and Akira Otaka*
More informationUV Tracer TM Maleimide NHS ester
UV Tracer TM Maleimide HS ester Product o.: 1020 Product ame: UV-Tracer TM Maleimide-HS ester Chemical Structure: Chemical Composition: C 41 H 67 5 18 Molecular Weight: 1014.08 Appearance: Storage: Yellow
More informationCYP2A6 and CYP2B6 are involved in nornicotine formation from nicotine in humans: Interindividual differences in these contributions
DMD Fast This article Forward. has not Published been copyedited on and August formatted. 31, The 2005 final version as doi:10.1124/dmd.105.006254 may differ from this version. CYP2A6 and CYP2B6 are involved
More informationHigh-Throughput CYP Inhibition Screening with Drug Probe Substrates: The RapidFire Advantage
High-Throughput CYP Inhibition Screening with Drug Probe Substrates: The RapidFire Advantage David M. Stresser, Ph.D. Program Manager BD Gentest SM Contract Research Services November 11, 2009 Presentation
More informationYUTAKA ODA and EVAN D. KHARASCH
0022-3565/01/2983-1021 1032$3.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 298, No. 3 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 3833/925681
More informationHepatic mitochondrial cytochrome P-450: Isolation
Proc. Nati. Acad. Sci. USA Vol. 74, No. 12, pp. 5477-5481, December 1977 Biochemistry Hepatic mitochondrial cytochrome P-45: Isolation and functional characterization (heme protein/liver mitochondria/bile
More informationCharacterization of CYP76AH4 clarifies phenolic diterpenoid biosynthesis in the Lamiaceae
Biochemistry, Biophysics and Molecular Biology Publications Biochemistry, Biophysics and Molecular Biology 2013 Characterization of CYP76AH4 clarifies phenolic diterpenoid biosynthesis in the Lamiaceae
More information